glp-1 agonist in esrd and the kidney: from physiology to pharmacology and outcomes diabetes Glucagon-Like Peptide-1 Receptor Agonist Use
Description
Vildagliptin appears to have a neutral effect, while saxagliptin has a negative effect on bone, increasing osteoclastic activity and decreasing osteocytic and osteoblastic activity in the femur in preclinical studies [108, 109, 109]
Mollan S, Hemmings K, Herd CP, Denton A, Williamson S, Sinclair AJ
Looking Ahead: Are you Strategically Positioned
J Investig Allergol Clin Immunol
[DOI] [PubMed] [Google Scholar] 80
